C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of CRH plc (NYSE:CRH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 25,846 shares of the construction company's stock, valued at approximately $2,335,000.
A number of other hedge funds also recently bought and sold shares of the business. Deseret Mutual Benefit Administrators bought a new stake in CRH during the 3rd quarter valued at approximately $25,000. Heck Capital Advisors LLC bought a new stake in CRH during the 4th quarter valued at approximately $32,000. Meeder Asset Management Inc. bought a new stake in CRH during the 3rd quarter valued at approximately $35,000. Baillie Gifford & Co. boosted its position in CRH by 70.7% during the 3rd quarter. Baillie Gifford & Co. now owns 391 shares of the construction company's stock valued at $36,000 after acquiring an additional 162 shares in the last quarter. Finally, Spire Wealth Management bought a new stake in CRH during the 4th quarter valued at approximately $57,000. Hedge funds and other institutional investors own 62.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on CRH. HSBC began coverage on CRH in a research report on Monday, November 11th. They issued a "buy" rating and a $116.00 price target on the stock. StockNews.com cut CRH from a "buy" rating to a "hold" rating in a research report on Wednesday. Barclays initiated coverage on CRH in a research report on Tuesday, October 29th. They issued an "overweight" rating and a $110.00 price target on the stock. Hsbc Global Res raised CRH to a "strong-buy" rating in a research report on Monday, November 11th. Finally, Citigroup lowered their price objective on CRH from $120.00 to $115.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $107.75.
View Our Latest Stock Analysis on CRH
CRH Stock Down 2.3 %
CRH traded down $2.33 during mid-day trading on Friday, reaching $100.26. 7,263,437 shares of the company traded hands, compared to its average volume of 4,189,201. The stock has a market capitalization of $68.09 billion, a P/E ratio of 20.05, a P/E/G ratio of 1.19 and a beta of 1.30. The company's fifty day moving average price is $97.93 and its 200-day moving average price is $94.36. CRH plc has a 52-week low of $71.18 and a 52-week high of $110.97.
About CRH
(
Free Report)
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.
Featured Stories

Before you consider CRH, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CRH wasn't on the list.
While CRH currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.